Open, Prospective, Multicentric, Single-arm, Non-interventional Study to Evaluate the Effectiveness and Safety of Oral Glucobay-M Tablets in Type 2 Diabetes Patient.

Trial Profile

Open, Prospective, Multicentric, Single-arm, Non-interventional Study to Evaluate the Effectiveness and Safety of Oral Glucobay-M Tablets in Type 2 Diabetes Patient.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Acarbose/metformin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms GLOBE
  • Sponsors Bayer
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Mar 2012 Actual patient number is 9664 according to ClinicalTrials.gov.
    • 05 Mar 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top